Through its antioxidant and anti-inflammatory effects, adiponectin inhibits the deleterious vascular effect of renin-angiotensin system activation and is closely related to dysregulation of blood pressure homeostasis in MS (67). The gene discussed is ADIPOQ; the disease is myeloid sarcoma.